NCT01799252

Brief Summary

The effectiveness of antibiotic treatment at reducing post-abortion infection is unclear. The experiences of women prescribed routine antibiotics after medical abortion is missing from the existing evidence. This study seeks to add to the literature evidence of the side effects associated with antibiotic treatment that women experience and their adherence to prescribed regimens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
582

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2012

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 7, 2012

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 26, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

February 3, 2014

Status Verified

January 1, 2014

Enrollment Period

1.1 years

First QC Date

December 7, 2012

Last Update Submit

January 30, 2014

Conditions

Keywords

medical abortiondoxycyclineantibioticsadherencenausea

Outcome Measures

Primary Outcomes (2)

  • Incidence rates of nausea

    Compare the incidence rates of nausea between women who are prescribed a seven-day regimen of doxycycline to women who are not prescribed antibiotics following medical abortion

    7-14 days following medical abortion

  • adherence

    Document the self-reported adherence to antibiotic regimens following medical abortion

    7-14 days following medical abortion

Secondary Outcomes (4)

  • Nausea rates

    7-14 days following medical abortion

  • Non-nausea side effects

    7-14 days following medical abortion

  • Additional medications

    7-14 days following medical abortion

  • Cost

    at time of filling prescription

Study Arms (2)

Doxy

Women who are prescribed a seven-day regimen of doxycycline following medical abortion

No Doxy

Women who are not prescribed antibiotics following medical abortion

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will enroll 610 women. Women will be recruited from 5 clinics and will self-administer, or if necessary, a study coordinator will administer, a computer-based questionnaire 7-14 days following administration of mifepristone.

You may qualify if:

  • Women who are having MA at the study clinic and are willing to complete a self-administered, computer-based questionnaire 7-14 days after taking mifepristone
  • Women who can read English or Spanish
  • In the doxycycline arm: Women who have been prescribed doxycycline

You may not qualify if:

  • Women who were treated with antibiotics for a medical condition unrelated to their medical abortion between the initial visit and follow-up appointment
  • Women who have previously enrolled in this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Feminist Women's Health Center

Atlanta, Georgia, 30329, United States

Location

Family Planning Associates

Chicago, Illinois, 60630, United States

Location

Planned Parenthood Mid and South Michigan

Ann Arbor, Michigan, 48104, United States

Location

Planned Parenthood MN, ND, SD

Saint Paul, Minnesota, 55114, United States

Location

Family Practice and Sidney Hillman Family Practice at the Institute for Family Health

New York, New York, 10003, United States

Location

NYU/Bellevue Hospital Center, Women's Health Center

New York, New York, 10016, United States

Location

Cedar River Clinic

Renton, Washington, 98057, United States

Location

Related Publications (1)

  • Frye LJ, Chong E, Winikoff B; NCT01799252 Trial Investigators. What happens when we routinely give doxycycline to medical abortion patients? Contraception. 2015 Jan;91(1):19-24. doi: 10.1016/j.contraception.2014.09.001. Epub 2014 Sep 15.

Related Links

MeSH Terms

Conditions

Nausea

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Beverly Winikoff, MD, MPH

    Gynuity Health Projects

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2012

First Posted

February 26, 2013

Study Start

November 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

February 3, 2014

Record last verified: 2014-01

Locations